Shorts

Minimal Adverse Events Associated With Tapinarof Cream

"Unscented" Isn't Fragrance-Free — Here's Why It Matters

Why Dermatopathology Is a Team Sport

The Hidden Stuggle Every Derm Nurse Feels

When Clinical Diagnosis Fails: The Role of Biopsies

The Psychological Toll of Vitiligo on Teens

Dermatology News Update - July 24

The Hidden Transformation of Skin Patients

Stop Using 'Adaptive Trials' as Just a Buzzword

One Night Of Bad Sleep Ruins Your Skin

How to Find the Best Sunscreen for Each Patient

Proving safety in new drug trials.

The Dangers of Decreasing Injection Frequency Too Fast

Is oral minoxidil safe for hair loss?

AI Models May Improve Risk Prediction in Early-Stage Melanoma

Lasers and DNA: How skin treatments impact cancer biology

A New Way to Treat Atopic Dermatitis?

Stop Using the Word 'Robust' in Dermatology

We Found a Way to Reverse Skin Aging at the Cellular Level

Prioritizing Skin Health Checks for Patients of All Skin Tones

The Only UV Safety Advice You Need This July

Why Patient Stratification Matters in Clinical Trials

The Importance of Early PsA Treatment for Joint Health

Why Your Acne Treatments May Not Be Working

Why patients are moving away from injectable psoriasis treatments

A Win for Patients and Providers: Roflumilast’s Expanded PsO Indication

Roflumilast Cream Approved for Children as Young as 2 With Plaque Psoriasis

Roflumilast Cream 0.3% Approved for Plaque Psoriasis Down to Age 2

Rethinking First-Line Treatment for Atopic Dermatitis

What AbbVie’s Acquisition of Apogee Means for AD Treatment